Chronic Osteomyelitis / Bone Infection Flap Reconstruction | Debridement, stability and coverage

Chronic osteomyelitis is treated as a spectrum. The wound may contain exposed, infected, devitalized bone and scarred tissue with poor blood supply. Debridement is performed like a tumor resection: all foreign material and nonviable tissue are removed, and bone is resected back to bleeding, viable tissue, sometimes using the paprika sign. Complete resection of involved bone, obliteration of dead space and well-vascularized flap coverage are central; local antibiotics may help when complete bone debridement is not possible. The extent is not based on defect size; a free flap can cover almost any hand or arm defect. Muscle and skin flaps each have pros and cons. Peripheral circulation can affect recurrence.

Chronic osteomyelitis is a long-standing bone infection that can leave bone changes or draining channels even after adequate antibiotics and cleaning surgery. Treatment removes dead or infected bone and scarred tissue, then rebuilds the gap. Rebuilding may use living bone transfer, bone grafting, gradual lengthening, or a combination. Complete cleaning, filling empty spaces, restoring bone shape and covering the area with healthy blood-rich tissue help control infection and restore function. Early problems can include limb shortening or lengthening and artery clotting; later problems can include fracture, bone instability, delayed or failed healing, poor alignment, and pain or swelling after walking.

Complex chronic osteomyelitis often needs radical debridement of infected bone and scarred tissue, obliteration of dead space, restoration of skeletal structure and well-vascularized coverage. When both bone and soft tissue are lost, combined orthopaedic and plastic surgery can address bony and soft-tissue reconstruction, sometimes in one stage, with close communication about incisions and flap protection. Muscle flaps offer high perfusion and antibiotic delivery, while newer evidence suggests fasciocutaneous perforator flaps can be equally effective in selected cases. Adhering to these principles can achieve primary remission above 90 percent, and the exact flap choice depends on defect size, circulation and donor-site considerations.

Chronic osteomyelitis often occurs with retained plates, screws, nails or prostheses. It is generally accepted that whenever possible all foreign objects should be removed. If removing them would compromise fracture reduction, articular congruity or joint integrity, alternative bony stabilization becomes mandatory. Rarely, a critical internal construct may be left in place only if absolutely necessary to preserve articular congruity during early fracture healing. External fixation can provide axial stabilization while allowing access to the wound. Separately, antibiotic beads, spacers and nails must be removed at definitive reimplantation, internal fixation, soft-tissue reconstruction or secondary bone grafting, although antibiotic-coated nails are often kept until uncomplicated union.

After adequate debridement, the remaining cavity can become a source of infection, so it must be filled. The goal is to replace dead bone and scar tissue with durable, well-blood-supplied tissue; local or free flaps may fill it, and bone grafts may be placed beneath transferred tissue. Antibiotic beads or cement can sterilize and temporarily maintain the space, usually removed after two to four weeks and replaced with bone graft. Muscle flaps offer strong blood flow and antibiotic delivery, while newer retrospective data suggest skin perforator flaps can be equally effective. Complete debridement, cavity filling, bone restoration and well-vascularized coverage are central; following these principles can yield primary remission over ninety percent.

Chronic osteomyelitis treatment centers on removing infected and dead bone, filling dead space with well-vascularized tissue, and using antibiotics. Local beads, spacers or nails release antibiotics into the wound by dilution and elution for many weeks to months, often reaching levels that can destroy biofilm bacteria. They must be removed at definitive reimplantation, fixation, reconstruction or bone grafting, although coated nails may remain until uncomplicated union. Perioperative antibiotics also play an important adjunctive role before and after definitive surgery. The exact role of local delivery compared with systemic antibiotics remains debated, and the usual six-week intravenous course lacks strong prospective confirmation. Your surgeon individualizes this.

Chronic bone infection treatment usually combines complete debridement, coverage with living tissue that has its own blood supply, and a short antibiotic course. This tissue fills the cavity, lowers bacterial load and supports healing. Muscle tissue has shown experimentally better blood flow, antibiotic delivery, oxygen levels, infection-fighting activity and lower bacterial counts than skin-only flaps. Clinically, thorough debridement and dead-space filling matter most; flap type seems less crucial. Both muscle and skin flaps can cover the area, with muscle giving bulk and skin flaps giving appearance. A retrospective study found skin perforator flaps equally effective in 120 cases. Following these principles can yield primary remission over 90%.

Chronic osteomyelitis reconstruction depends on radical debridement, dead-space obliteration and well-vascularized coverage. Local muscle flaps are commonly used for proximal or middle tibial defects, while distal-third tibial defects often require microvascular free muscle transfer. Free fasciocutaneous flaps can suit shallow defects needing less bulk. Muscle flaps may improve perfusion and antibiotic delivery, but complete debridement and vascular status matter more than flap type; reported primary remission can exceed 90%. Local flaps are simpler with shorter operating time, whereas free flaps may allow shorter hospital stay because of more reliable blood supply. Adequate initial debridement helps ensure flap success. Not all limbs can be salvaged; amputation may be discussed.

Skin graft survival depends on new blood vessels growing from the wound bed. When bone is exposed and its covering is lost, that blood supply is absent, so the graft may not take. In chronic osteomyelitis, infected and scarred tissue must be removed, and dead space filled with tissue that has its own blood supply. Such flaps improve blood flow and antibiotic delivery and provide durable coverage; a skin graft may then cover remaining superficial areas. A graft is also less suitable where firm sticking would limit movement or further surgery is planned beneath it. Flap choice depends on the defect and circulation. When debridement and well-vascularized coverage principles are followed, primary remission over 90% has been reported.

Chronic osteomyelitis is a persistent infection with bone changes or sinus tracts after adequate antibiotics and debridement. Successful treatment depends on adequate debridement and culture-directed antibiotics, with vascularized tissue to fill and obliterate the bony and soft-tissue defect, regardless of the flap chosen. For acute osteomyelitis, standard antibiotic therapy is 3 to 6 weeks with surgery. After debridement, a flap may be raised 2 to 4 weeks later to remove antibiotic beads and place cancellous bone graft. Severe soft-tissue loss may need a muscle flap, beads and skin graft, then secondary bone grafting. Single-stage replacement of soft tissue and bone can salvage limbs that would otherwise be lost or require a protracted reconstructive course.